The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 53 (1) , 93-105
- https://doi.org/10.1016/s0031-6997(24)01481-9
Abstract
No abstract availableThis publication has 494 references indexed in Scilit:
- The expression of transforming growth factor-?1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinomaCancer, 1999
- Immunohistochemical study of sialyl le a and sialyl le x antigen in oral squamous cell carcinoma: The association of sialyl le a expression with the metastatic potentialHead & Neck, 1999
- Identification of a heparin binding site and the biological activities of the laminin ?1 chain carboxy-terminal globular domainJournal of Cellular Physiology, 1999
- Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesisInternational Journal of Cancer, 1999
- Heparin rapidly and selectively regulates protein tyrosine phosphorylation in vascular smooth muscle cellsJournal of Cellular Physiology, 1999
- Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancerThe Prostate, 1998
- Extracellular matrix modulates expression of growth factors and growth-factor receptors in liver-colonizing colon-cancer cell linesInternational Journal of Cancer, 1998
- Role of αIIbβ3 integrin in prostate cancer metastasisThe Prostate, 1998
- General mechanisms of metastasisCancer, 1997
- Ectopic expression of platelet integrin αIIbβ3 in tumor cells from various species and histological originInternational Journal of Cancer, 1997